. (CALP)
$10.49 - (-)
Market Cap: -
As of 12/22/11 12:00 AM EST. Market closed.
. (CALP)
$10.49
- (-)
Market Cap: -
As of 12/22/11 12:00 AM EST. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$10.49
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$10.49
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| TUNSTALL KATHRYN | Director | Nov 07, 2011 | Option Exercise | $10.50 | 25,107 | 263,624 | 0 | Nov 07, 2011, 04:48 PM |
| MILLIGAN DAVID V | Director | Nov 07, 2011 | Option Exercise | $10.50 | 81,729 | 858,155 | 0 | Nov 07, 2011, 04:46 PM |
| MCAREE PETER F | Sr.VP and CFO | Nov 07, 2011 | Option Exercise | $10.50 | 62,786 | 659,253 | 0 | Nov 07, 2011, 04:45 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Nov 07, 2011 | Option Exercise | $10.50 | 423,242 | 4,444,041 | 0 | Nov 07, 2011, 04:43 PM |
| KRUKA WILLIAM C. | Sr VP Corporate Development | Nov 07, 2011 | Option Exercise | $10.50 | 82,240 | 863,520 | 0 | Nov 07, 2011, 04:40 PM |
| HRUSOVSKY E KEVIN | President & CEO | Nov 07, 2011 | Option Exercise | $10.50 | 826,725 | 8,680,613 | 0 | Nov 07, 2011, 04:39 PM |
| Griffith Joseph H. IV | VP, Finance & Controller | Nov 07, 2011 | Option Exercise | $10.50 | 33,287 | 349,514 | 0 | Nov 07, 2011, 04:37 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Nov 07, 2011 | Option Exercise | $10.50 | 43,953 | 461,507 | 0 | Nov 07, 2011, 04:36 PM |
| Comstock Allan L | Director | Nov 07, 2011 | Option Exercise | $10.50 | 26,107 | 274,124 | 0 | Nov 07, 2011, 04:34 PM |
| CARTER DAVID WARREN | Director | Nov 07, 2011 | Option Exercise | $10.50 | 38,173 | 400,817 | 0 | Nov 07, 2011, 04:27 PM |
| CARTER DAVID WARREN | Director | Nov 07, 2011 | Option Exercise | $10.50 | 184,589 | 1,938,185 | 0 | Nov 07, 2011, 04:27 PM |
| BISHOP ROBERT C | Director | Nov 07, 2011 | Option Exercise | $10.50 | 26,814 | 281,547 | 0 | Nov 07, 2011, 04:26 PM |
| BILLET VAN | Director | Nov 07, 2011 | Option Exercise | $10.50 | 25,107 | 263,624 | 0 | Nov 07, 2011, 04:24 PM |
| BAL BRUCE J | Sr.VP, Operations | Nov 07, 2011 | Option Exercise | $10.50 | 126,279 | 1,325,930 | 0 | Nov 07, 2011, 04:22 PM |
| HRUSOVSKY E KEVIN | President & CEO | Oct 31, 2011 | Option Exercise | $5.17 | 179,407 | 928,250 | 826,725 | Nov 02, 2011, 04:44 PM |
| HRUSOVSKY E KEVIN | President & CEO | Aug 09, 2011 | Option Exercise | $6.79 | 2,472 | 16,785 | 647,318 | Nov 02, 2011, 04:44 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Nov 01, 2011 | Sale | $10.47 | 5,000 | 52,344 | 43,953 | Nov 01, 2011, 04:39 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Oct 03, 2011 | Sale | $10.45 | 5,000 | 52,250 | 48,953 | Oct 03, 2011, 04:50 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Sep 01, 2011 | Sale | $7.52 | 5,000 | 37,602 | 51,104 | Sep 01, 2011, 04:20 PM |
| CARTER DAVID WARREN | Director | Aug 01, 2011 | Option Exercise | $6.79 | 30,167 | 204,834 | 23,427 | Aug 24, 2011, 05:02 PM |
| CARTER DAVID WARREN | Director | Jul 15, 2011 | Option Exercise | $6.79 | 8,006 | 54,361 | 8,006 | Aug 24, 2011, 05:02 PM |
| CARTER DAVID WARREN | Director | Aug 01, 2011 | Option Exercise | $6.79 | 17,371 | 117,949 | 184,589 | Aug 24, 2011, 05:02 PM |
| CARTER DAVID WARREN | Director | Jul 15, 2011 | Option Exercise | $6.79 | 26,152 | 177,572 | 167,218 | Aug 24, 2011, 05:02 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Aug 01, 2011 | Sale | $8.20 | 5,000 | 41,007 | 56,104 | Aug 02, 2011, 04:31 PM |
| CARTER DAVID WARREN | Director | Jul 12, 2011 | Option Exercise | $6.79 | 1,082 | 7,347 | 141,066 | Jul 13, 2011, 04:51 PM |
| CARTER DAVID WARREN | Director | Jul 11, 2011 | Option Exercise | $6.29 | 2,787 | 17,519 | 139,984 | Jul 13, 2011, 04:51 PM |
| Griffith Joseph H. IV | VP, Finance & Controller | Jul 01, 2011 | Option Exercise | $8.12 | 397 | 3,224 | 33,287 | Jul 05, 2011, 04:41 PM |
| MCAREE PETER F | Sr.VP and CFO | Jul 01, 2011 | Sale | $8.10 | 5,000 | 40,475 | 59,886 | Jul 05, 2011, 04:23 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Jul 01, 2011 | Sale | $8.11 | 5,000 | 40,543 | 61,104 | Jul 05, 2011, 04:15 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Jun 14, 2011 | Sale | $7.54 | 18,902 | 142,587 | 420,212 | Jun 15, 2011, 04:39 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Jun 13, 2011 | Sale | $7.56 | 1,098 | 8,301 | 439,114 | Jun 15, 2011, 04:39 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Jun 08, 2011 | Sale | $7.18 | 15,000 | 107,700 | 450,212 | Jun 09, 2011, 04:26 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Jun 09, 2011 | Sale | $7.48 | 10,000 | 74,800 | 440,212 | Jun 09, 2011, 04:26 PM |
| TUNSTALL KATHRYN | Director | Jun 03, 2011 | Option Exercise | $7.20 | 4,375 | 31,500 | 25,107 | Jun 07, 2011, 04:40 PM |
| MILLIGAN DAVID V | Director | Jun 03, 2011 | Option Exercise | $7.20 | 4,375 | 31,500 | 25,107 | Jun 07, 2011, 04:39 PM |
| CARTER DAVID WARREN | Director | Jun 03, 2011 | Option Exercise | $7.20 | 4,375 | 31,500 | 137,197 | Jun 07, 2011, 04:33 PM |
| BISHOP ROBERT C | Director | Jun 03, 2011 | Option Exercise | $7.20 | 6,250 | 45,000 | 26,814 | Jun 07, 2011, 04:32 PM |
| BILLET VAN | Director | Jun 03, 2011 | Option Exercise | $7.20 | 4,375 | 31,500 | 25,107 | Jun 07, 2011, 04:31 PM |
| Comstock Allan L | Director | Jun 03, 2011 | Option Exercise | $7.20 | 4,375 | 31,500 | 26,107 | Jun 07, 2011, 04:30 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Jun 01, 2011 | Sale | $7.18 | 15,000 | 107,700 | 465,212 | Jun 02, 2011, 04:32 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | May 25, 2011 | Sale | $7.08 | 15,000 | 106,200 | 480,212 | May 26, 2011, 04:27 PM |
| HRUSOVSKY E KEVIN | President & CEO | Apr 04, 2011 | Option Exercise | $6.80 | 8,750 | 59,500 | 640,587 | Apr 05, 2011, 04:22 PM |
| HRUSOVSKY E KEVIN | President & CEO | Mar 07, 2011 | Option Exercise | $6.57 | 10,000 | 65,700 | 631,837 | Apr 05, 2011, 04:21 PM |
| HRUSOVSKY E KEVIN | President & CEO | Mar 03, 2011 | Option Exercise | $6.76 | 62,500 | 422,500 | 621,837 | Apr 05, 2011, 04:21 PM |
| MCAREE PETER F | Sr.VP and CFO | Apr 01, 2011 | Sale | $6.70 | 5,000 | 33,490 | 64,886 | Apr 04, 2011, 04:25 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Apr 01, 2011 | Sale | $6.66 | 5,000 | 33,305 | 66,104 | Apr 04, 2011, 04:23 PM |
| MCAREE PETER F | Sr.VP and CFO | Mar 07, 2011 | Option Exercise | $6.57 | 1,350 | 8,870 | 72,786 | Mar 07, 2011, 04:57 PM |
| MCAREE PETER F | Sr.VP and CFO | Mar 03, 2011 | Option Exercise | $6.76 | 3,172 | 21,443 | 69,886 | Mar 07, 2011, 04:57 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Mar 07, 2011 | Option Exercise | $6.57 | 1,470 | 9,658 | 498,242 | Mar 07, 2011, 04:56 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Mar 03, 2011 | Option Exercise | $6.76 | 3,687 | 24,924 | 495,212 | Mar 07, 2011, 04:56 PM |
| KRUKA WILLIAM C. | Sr VP Corporate Development | Mar 07, 2011 | Option Exercise | $6.57 | 1,651 | 10,847 | 79,775 | Mar 07, 2011, 04:55 PM |
| KRUKA WILLIAM C. | Sr VP Corporate Development | Mar 03, 2011 | Option Exercise | $6.76 | 4,081 | 27,588 | 76,926 | Mar 07, 2011, 04:55 PM |
| Griffith Joseph H. IV | VP, Finance & Controller | Mar 03, 2011 | Option Exercise | $6.76 | 3,131 | 21,166 | 32,241 | Mar 07, 2011, 04:49 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Mar 07, 2011 | Option Exercise | $6.57 | 1,651 | 10,847 | 73,953 | Mar 07, 2011, 04:47 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Mar 03, 2011 | Option Exercise | $6.76 | 4,116 | 27,824 | 71,104 | Mar 07, 2011, 04:47 PM |
| BAL BRUCE J | Sr.VP, Operations | Mar 07, 2011 | Option Exercise | $6.57 | 1,429 | 9,389 | 126,279 | Mar 07, 2011, 04:46 PM |
| BAL BRUCE J | Sr.VP, Operations | Mar 03, 2011 | Option Exercise | $6.76 | 3,131 | 21,166 | 123,208 | Mar 07, 2011, 04:46 PM |
| CARTER DAVID WARREN | Director | Mar 02, 2011 | Sale | $6.51 | 28,483 | 185,424 | 0 | Mar 04, 2011, 04:40 PM |
| MCAREE PETER F | Sr.VP and CFO | Feb 28, 2011 | Option Exercise | $6.69 | 719 | 4,810 | 63,433 | Feb 28, 2011, 04:53 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Feb 28, 2011 | Option Exercise | $6.69 | 1,106 | 7,399 | 487,774 | Feb 28, 2011, 04:52 PM |
| KRUKA WILLIAM C. | Sr VP Corporate Development | Feb 28, 2011 | Option Exercise | $6.69 | 1,510 | 10,102 | 69,882 | Feb 28, 2011, 04:50 PM |
| HRUSOVSKY E KEVIN | President & CEO | Feb 23, 2011 | Option Exercise | $6.57 | 25,000 | 164,250 | 559,337 | Feb 28, 2011, 04:49 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Feb 28, 2011 | Option Exercise | $6.69 | 1,564 | 10,463 | 64,095 | Feb 28, 2011, 04:48 PM |
| BAL BRUCE J | Sr.VP, Operations | Feb 28, 2011 | Option Exercise | $6.69 | 1,349 | 9,025 | 116,714 | Feb 28, 2011, 04:47 PM |
| MCAREE PETER F | Sr.VP and CFO | Feb 23, 2011 | Option Exercise | $6.57 | 1,978 | 12,995 | 62,152 | Feb 25, 2011, 04:29 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Feb 23, 2011 | Option Exercise | $6.57 | 1,798 | 11,813 | 485,880 | Feb 25, 2011, 04:28 PM |
| KRUKA WILLIAM C. | Sr VP Corporate Development | Feb 23, 2011 | Option Exercise | $6.57 | 2,572 | 16,898 | 67,642 | Feb 25, 2011, 04:27 PM |
| Griffith Joseph H. IV | VP, Finance & Controller | Feb 23, 2011 | Option Exercise | $6.57 | 899 | 5,906 | 28,518 | Feb 25, 2011, 04:24 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Feb 23, 2011 | Option Exercise | $6.57 | 2,058 | 13,521 | 61,909 | Feb 25, 2011, 04:23 PM |
| BAL BRUCE J | Sr.VP, Operations | Feb 23, 2011 | Option Exercise | $6.57 | 1,798 | 11,813 | 114,313 | Feb 25, 2011, 04:23 PM |
| MCAREE PETER F | Sr.VP and CFO | Jan 18, 2011 | Sale | $6.49 | 7,500 | 48,649 | 58,630 | Jan 20, 2011, 04:31 PM |
| CREAGER STEPHEN E | Sr. VP and General Counsel | Jan 18, 2011 | Sale | $6.44 | 10,000 | 64,448 | 58,967 | Jan 20, 2011, 04:29 PM |
| CARTER DAVID WARREN | Director | Nov 02, 2010 | Sale | $4.50 | 6,795 | 30,586 | 35,278 | Nov 03, 2010, 04:16 PM |
| CARTER DAVID WARREN | Director | Nov 02, 2010 | Sale | $4.56 | 2,700 | 12,320 | 132,822 | Nov 03, 2010, 04:16 PM |
| CARTER DAVID WARREN | Director | Nov 02, 2010 | Sale | $4.52 | 9,495 | 42,906 | 35,278 | Nov 03, 2010, 04:16 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Oct 15, 2010 | Sale | $4.24 | 4,000 | 16,960 | 490,723 | Oct 15, 2010, 04:21 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Oct 14, 2010 | Sale | $4.20 | 4,000 | 16,800 | 494,723 | Oct 15, 2010, 04:21 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Oct 11, 2010 | Sale | $4.14 | 2,800 | 11,580 | 508,723 | Oct 13, 2010, 04:33 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Oct 13, 2010 | Sale | $4.20 | 4,000 | 16,800 | 498,723 | Oct 13, 2010, 04:33 PM |
| Manyak David M | Exec VP, Drug Discovery Svcs | Oct 12, 2010 | Sale | $4.17 | 5,200 | 21,700 | 505,923 | Oct 13, 2010, 04:33 PM |
| KRUKA WILLIAM C. | Sr VP Corporate Development | Aug 10, 2010 | Sale | $3.80 | 12,300 | 46,768 | 71,200 | Aug 11, 2010, 04:29 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| TUNSTALL KATHRYN | Director | 11/07/2011 | 263,624 |
| MILLIGAN DAVID V | Director | 11/07/2011 | 858,155 |
| MCAREE PETER F | Sr.VP and CFO | 11/07/2011 | 659,253 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 11/07/2011 | 4,444,041 |
| KRUKA WILLIAM C. | Sr VP Corporate Development | 11/07/2011 | 863,520 |
| HRUSOVSKY E KEVIN | President & CEO | 11/07/2011 | 8,680,613 |
| Griffith Joseph H. IV | VP, Finance & Controller | 11/07/2011 | 349,514 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 11/07/2011 | 461,507 |
| Comstock Allan L | Director | 11/07/2011 | 274,124 |
| CARTER DAVID WARREN | Director | 11/07/2011 | 400,817 |
| CARTER DAVID WARREN | Director | 11/07/2011 | 1,938,185 |
| BISHOP ROBERT C | Director | 11/07/2011 | 281,547 |
| BILLET VAN | Director | 11/07/2011 | 263,624 |
| BAL BRUCE J | Sr.VP, Operations | 11/07/2011 | 1,325,930 |
| HRUSOVSKY E KEVIN | President & CEO | 10/31/2011 | 928,250 |
| HRUSOVSKY E KEVIN | President & CEO | 08/09/2011 | 16,785 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 11/01/2011 | 52,344 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 10/03/2011 | 52,250 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 09/01/2011 | 37,602 |
| CARTER DAVID WARREN | Director | 08/01/2011 | 204,834 |
| CARTER DAVID WARREN | Director | 07/15/2011 | 54,361 |
| CARTER DAVID WARREN | Director | 08/01/2011 | 117,949 |
| CARTER DAVID WARREN | Director | 07/15/2011 | 177,572 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 08/01/2011 | 41,007 |
| CARTER DAVID WARREN | Director | 07/12/2011 | 7,347 |
| CARTER DAVID WARREN | Director | 07/11/2011 | 17,519 |
| Griffith Joseph H. IV | VP, Finance & Controller | 07/01/2011 | 3,224 |
| MCAREE PETER F | Sr.VP and CFO | 07/01/2011 | 40,475 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 07/01/2011 | 40,543 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 06/14/2011 | 142,587 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 06/13/2011 | 8,301 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 06/08/2011 | 107,700 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 06/09/2011 | 74,800 |
| TUNSTALL KATHRYN | Director | 06/03/2011 | 31,500 |
| MILLIGAN DAVID V | Director | 06/03/2011 | 31,500 |
| CARTER DAVID WARREN | Director | 06/03/2011 | 31,500 |
| BISHOP ROBERT C | Director | 06/03/2011 | 45,000 |
| BILLET VAN | Director | 06/03/2011 | 31,500 |
| Comstock Allan L | Director | 06/03/2011 | 31,500 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 06/01/2011 | 107,700 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 05/25/2011 | 106,200 |
| HRUSOVSKY E KEVIN | President & CEO | 04/04/2011 | 59,500 |
| HRUSOVSKY E KEVIN | President & CEO | 03/07/2011 | 65,700 |
| HRUSOVSKY E KEVIN | President & CEO | 03/03/2011 | 422,500 |
| MCAREE PETER F | Sr.VP and CFO | 04/01/2011 | 33,490 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 04/01/2011 | 33,305 |
| MCAREE PETER F | Sr.VP and CFO | 03/07/2011 | 8,870 |
| MCAREE PETER F | Sr.VP and CFO | 03/03/2011 | 21,443 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 03/07/2011 | 9,658 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 03/03/2011 | 24,924 |
| KRUKA WILLIAM C. | Sr VP Corporate Development | 03/07/2011 | 10,847 |
| KRUKA WILLIAM C. | Sr VP Corporate Development | 03/03/2011 | 27,588 |
| Griffith Joseph H. IV | VP, Finance & Controller | 03/03/2011 | 21,166 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 03/07/2011 | 10,847 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 03/03/2011 | 27,824 |
| BAL BRUCE J | Sr.VP, Operations | 03/07/2011 | 9,389 |
| BAL BRUCE J | Sr.VP, Operations | 03/03/2011 | 21,166 |
| CARTER DAVID WARREN | Director | 03/02/2011 | 185,424 |
| MCAREE PETER F | Sr.VP and CFO | 02/28/2011 | 4,810 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 02/28/2011 | 7,399 |
| KRUKA WILLIAM C. | Sr VP Corporate Development | 02/28/2011 | 10,102 |
| HRUSOVSKY E KEVIN | President & CEO | 02/23/2011 | 164,250 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 02/28/2011 | 10,463 |
| BAL BRUCE J | Sr.VP, Operations | 02/28/2011 | 9,025 |
| MCAREE PETER F | Sr.VP and CFO | 02/23/2011 | 12,995 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 02/23/2011 | 11,813 |
| KRUKA WILLIAM C. | Sr VP Corporate Development | 02/23/2011 | 16,898 |
| Griffith Joseph H. IV | VP, Finance & Controller | 02/23/2011 | 5,906 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 02/23/2011 | 13,521 |
| BAL BRUCE J | Sr.VP, Operations | 02/23/2011 | 11,813 |
| MCAREE PETER F | Sr.VP and CFO | 01/18/2011 | 48,649 |
| CREAGER STEPHEN E | Sr. VP and General Counsel | 01/18/2011 | 64,448 |
| CARTER DAVID WARREN | Director | 11/02/2010 | 30,586 |
| CARTER DAVID WARREN | Director | 11/02/2010 | 12,320 |
| CARTER DAVID WARREN | Director | 11/02/2010 | 42,906 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 10/15/2010 | 16,960 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 10/14/2010 | 16,800 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 10/11/2010 | 11,580 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 10/13/2010 | 16,800 |
| Manyak David M | Exec VP, Drug Discovery Svcs | 10/12/2010 | 21,700 |
| KRUKA WILLIAM C. | Sr VP Corporate Development | 08/10/2010 | 46,768 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...